0001237899-21-000017.txt : 20210824
0001237899-21-000017.hdr.sgml : 20210824
20210824160445
ACCESSION NUMBER: 0001237899-21-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210820
FILED AS OF DATE: 20210824
DATE AS OF CHANGE: 20210824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211202250
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-20
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Controller
Common Stock
2021-08-20
4
M
0
13500
179.13
A
32520
D
Common Stock
2021-08-23
4
S
0
4576
655.0
D
27944
D
Common Stock
2021-08-23
4
S
0
9
659.33
D
27935
D
Common Stock
2021-08-23
4
S
0
23
660.33
D
27912
D
Common Stock
2021-08-23
4
S
0
88
661.89
D
27824
D
Common Stock
2021-08-23
4
S
0
1
662.78
D
27823
D
Common Stock
2021-08-23
4
S
0
70
663.05
D
27753
D
Common Stock
2021-08-23
4
S
0
14
665.21
D
27739
D
Common Stock
2082
I
2021 GRAT
Common Stock
1459
I
By 401(k) Plan
Common Stock
1897
I
By Trust
Common Stock
1861
I
by 2018 GRAT
Common Stock
25
I
by Trust for Daugh
Common Stock
25
I
by Trust for Son
Non-Qualified Stock Option (right to buy)
179.13
2021-08-20
4
M
0
13500
0.0
D
2022-12-14
Common Stock
13500
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 9 shares of Company stock on August 23, 2021 at prices ranging from $659.28 to $659.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Represents volume-weighted average price of sales of 23 shares of Company stock on August 23, 2021 at prices ranging from $660.09 to $660.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Represents volume-weighted average price of sales of 88 shares of Company stock on August 23, 2021 at prices ranging from $661.47 to $661.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
Represents volume-weighted average price of sales of 70 shares of Company stock on August 23, 2021 at prices ranging from $663.00 to $663.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2021-08-23